MCF-7; a human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors
- PMID: 175527
- DOI: 10.1016/0039-128x(75)90110-5
MCF-7; a human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors
Abstract
We have identified receptors for glucocorticoids, progestins, and androgens in a human breast tumor cell line (MCF-7) known to have estrogen receptor. Sucrose density gradients show that MCF-7 cytosol contains approximately 100 fm/mg protein estradiol (E2-3H) receptor, more than 300 fm/mg protein progesterone receptor (measured with R5020-3H), about 40 fm/mg protein 5alpha-dihydrotestosterone (5alpha-DHT-3H) receptor, and 800 fm/mg glucocorticoid receptor (measured with dexamethasone-3H). Dissociation constants obtained by Scatchard analyses were approximately 0.6 x 10(-10)M (E2), 1 x 10(-9)M (R5020), 2.8 x 10(-10)M (5alpha-DHT) and 8 x 10(-9)M (dexamethasone). No cross competition was found for estrogen receptor, but progestins competed for androgen and glucocorticoid binding. The androgen, but not the glucocorticoid, partially competed for R5020 binding to progesterone receptor. This first demonstration of 4 classes of steroid receptors in human breast cancer means that MCF-7 may be an excellent in vitro model for studying the mechanism of tumor response to endocrine therapy as well as the complex relationships between binding and biological actions of these hormones.
Similar articles
-
Specific progesterone receptors in human breast cancer.Steroids. 1975 Apr;25(4):497-505. doi: 10.1016/0039-128x(75)90027-6. Steroids. 1975. PMID: 165596
-
Estrogen down-regulation of androgen receptors in cultured human mammary cancer cells (MCF-7).Endocrinology. 1987 Jun;120(6):2597-603. doi: 10.1210/endo-120-6-2597. Endocrinology. 1987. PMID: 3569146
-
The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture.Cancer Res. 1976 Dec;36(12):4610-8. Cancer Res. 1976. PMID: 1000506
-
Steroid-binding proteins of the mammary gland and their clinical significance in breast cancer.J Toxicol Environ Health Suppl. 1976;1:231-56. J Toxicol Environ Health Suppl. 1976. PMID: 186628 Review.
-
The role of hypothalamic and hypophyseal 5alpha-dihydrotestosterone, estradiol and progesterone receptors in the mechanism of feedback action.J Steroid Biochem. 1975 Jun;6(6):979-87. J Steroid Biochem. 1975. PMID: 170464 Review. No abstract available.
Cited by
-
Low ozone concentrations do not exert cytoprotective effects on tamoxifen-treated breast cancer cells in vitro.Eur J Histochem. 2024 Sep 9;68(3):4106. doi: 10.4081/ejh.2024.4106. Eur J Histochem. 2024. PMID: 39252536 Free PMC article.
-
Nucleocytoplasmic shuttling of the progesterone receptor.EMBO J. 1991 Dec;10(12):3851-9. doi: 10.1002/j.1460-2075.1991.tb04954.x. EMBO J. 1991. PMID: 1935904 Free PMC article.
-
Novel Arylsulfonylhydrazones as Breast Anticancer Agents Discovered by Quantitative Structure-Activity Relationships.Molecules. 2023 Feb 22;28(5):2058. doi: 10.3390/molecules28052058. Molecules. 2023. PMID: 36903304 Free PMC article.
-
90 YEARS OF PROGESTERONE: Progesterone and progesterone receptors in breast cancer: past, present, future.J Mol Endocrinol. 2020 Jul;65(1):T49-T63. doi: 10.1530/JME-20-0104. J Mol Endocrinol. 2020. PMID: 32485679 Free PMC article. Review.
-
Biochanin A inhibits breast cancer tumor growth in a murine xenograft model.Pharm Res. 2008 Sep;25(9):2158-63. doi: 10.1007/s11095-008-9583-6. Epub 2008 May 3. Pharm Res. 2008. PMID: 18454305
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials